Status:
COMPLETED
Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT)
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Princess Margaret Hospital, Canada
Conditions:
Carcinoma, Squamous Cell
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This study is examining the effects of increasing the dose of radiation given to treat head and neck cancer. Radiation doses to the primary cancer are higher than usually given; lymph glands of the ne...
Eligibility Criteria
Inclusion
- Histologically proven squamous cell carcinoma
- Larynx \& pharynx (except Nasopharyngeal carcinoma)
- Stage III \& IV, but any stage hypopharynx
- Informed Consent
Exclusion
- \-
Key Trial Info
Start Date :
June 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
169 Patients enrolled
Trial Details
Trial ID
NCT00188318
Start Date
June 1 1998
End Date
May 1 2010
Last Update
February 9 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9